Tackling scabies: novel agents for a neglected disease

Area of Science:

• Dermatology
• Parasitology
• Medical Entomology

Background:

• Scabies, caused by the mite Sarcoptes scabiei var hominis, is a significant global health concern.
• Emerging resistance to acaricidal treatments and treatment failures pose challenges in managing scabies, particularly in endemic regions and severe cases like crusted scabies.

Purpose of the Study:

• To review diverse and novel approaches for scabies management.
• To explore the potential of new therapeutic strategies against Sarcoptes scabiei.

Main Methods:

• Review of recent scientific literature on scabies treatment and management.
• Analysis of emerging therapeutic avenues including plant-derived products, veterinary drug translation, immunotherapy, and molecularly targeted drugs.

Main Results:

• Current acaricidal agents face challenges due to emerging resistance and treatment failures.
• Novel strategies show promise, including plant-based products, moxidectin, vaccination, immunotherapy, and drugs targeting mite molecules.

Conclusions:

• There is a critical need for novel agents to overcome scabies treatment failures and resistance.
• Further research into mite biology, pathogenesis, and innovative therapeutic approaches is essential for effective scabies control.